# TAZAROTENE
> **ANDA211175** · Abbreviated New Drug Application (Generic) · Sponsor: FOUGERA PHARMS INC · Approved 2019-01-28
## Drug
- **FDA Application Number:** ANDA211175
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** TAZAROTENE
- **Generic name:** Tazarotene
- **Active ingredients:** TAZAROTENE
- **Dosage form:** CREAM
- **Route:** TOPICAL
- **Marketing status:** Discontinued
- **Sponsor:** FOUGERA PHARMS INC
- **First approval:** 2019-01-28
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211175)
---
*MORVS · CC0 1.0*